東方電子(000682.SZ):東方茸世以2000萬元投資先楫半導體
格隆匯10月19日丨東方電子(000682.SZ)公佈,日前,東方茸世與上海先楫半導體科技有限公司及其原股東簽署了《增資協議》。
公吿顯示,標的公司上海先楫半導體科技有限公司(“先楫半導體”)主要產品:高性能嵌入式半導體解決方案,產品覆蓋微控制器、微處理器和配套的周邊芯片,以及為其服務的開發工具和生態系統。
東方茸世投資2000萬元人民幣,認購先楫半導體新增註冊資本4.5463萬元人民幣,增資完成後東方茸世持有先楫半導體的股權比例為2.7972%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.